CN1415323A

CN1415323A - Patent Chinese medicine for treating diabetes

Info

Publication number: CN1415323A
Application number: CN 02127906
Authority: CN
Inventors: 孙平
Original assignee: JIANXING MEDICAL INDUSTRY Co Ltd GUIZHOU
Current assignee: JIANXING MEDICAL INDUSTRY Co Ltd GUIZHOU
Priority date: 2002-11-29
Filing date: 2002-11-29
Publication date: 2003-05-07
Anticipated expiration: 2022-11-29
Also published as: CN1172705C

Abstract

A Chinese patent medicine for treating insulin-independent diabetes and its complications is prepared from 7 Chinese-medicinal materials including scutellaria root, mulberry lefa, arctium fruit, barbat skullcap, etc. Its advantages are high curative effect and low cost.

Description

The Chinese patent medicine of treatment diabetes

Technical field: the present invention is a kind of Chinese patent medicine for the treatment of diabetes, particularly the Chinese patent medicine of making of pure Chinese herbal medicine.

Technical background: diabetes are frequently-occurring diseases of serious harm human health, and at present there is the patient in China near 20,000,000, and have and increase trend year by year, and case fatality rate is only second to malignant tumor and cardiovascular disease, is to jeopardize the third-largest disease of human life; Diabetes do not heal all the life, complication extensively and seriously, because insulin lacks relatively or definitely in the blood flow, cause sugar, fat, protein metabolism disorder, cause the rising of hypertension, hyperlipidemia and blood viscosity, extensively microangiopathies of the whole body appears in middle and advanced stage, and wherein the patient of 70-80% dies from the cardiovascular diseases, and renal failure and cerebrovascular accident are the common causes of death of middle and elderly diabetic patient; To what this sick Drug therapy adopted be both at home and abroad at present: 1, biguanides medicine treatment, its curative effect is low, side effect is big, for a long time with producing hyperlactacidemia; 2, iodine ureas medicine is treated it for a long time with infringement liver, kidney and hemocyte, and with the sulphonamides cross allergy, the later stage produces secondary failure; 3, insulinize, the easily generation antibody of using of a specified duration, biological activity reduces, and dosage increase, generation hyperinsulinemia promote the microangiopathies generation and develop.Though China recent years has some to treat this sick Chinese patent medicine, because DeGrain, the patient still has to rely on some Western medicine, so still has the problems referred to above.

Summary of the invention: the objective of the invention is to: a kind of Chinese patent medicine for the treatment of diabetes is provided, this medicine is to develop on the proved recipe basis that the compatriot of China Miao ethnic group uses for a long time, have YIN nourishing and the production of body fluid promoting, grow the function of spleen the kidney invigorating, QI invigorating blood sugar lowering, be used for diabetes, cure mainly non-insulin-dependent diabetes mellitus and retina, kidney, blood vessel, neurological complication; The present invention constitutes like this: it is made of Radix Scutellariae 580-650, Folium Mori 250-230, Fructus Arctii 230-300, Radix Wahlenbergiae Marginatae 150-220, Herba Scutellariae Barbatae 140-200, Rhizoma Polygonati Odorati 100-140, Semen Celosiae 80-110; Specifically: form by Radix Scutellariae 620 grams, Folium Mori 285 grams, Fructus Arctii 260 grams, Radix Wahlenbergiae Marginatae 180 grams, Herba Scutellariae Barbatae 170 grams, Rhizoma Polygonati Odorati 120 grams, Semen Celosiae 93 grams.More specific method is: get the part powder of Folium Mori and be broken into fine powder, all the other Folium Mori and other medical material water decoct, extracting solution concentrates, and add Folium Mori fine powder, drying, pulverizing then,

To medicine, can be made into the dosage form of needs according to prior art; The extraction of the active ingredient of medical material can be adopted solvent, comprises method and supercritical carbon dioxide extraction that water, alcohol decoct, soak.Compared with prior art: the present invention constitute fairly simple, manufacture method is easy, cost of drugs is cheap, the patient is acceptant, medicine really has YIN nourishing and the production of body fluid promoting, grows the function of spleen the kidney invigorating, QI invigorating blood sugar lowering, is used for diabetes, cures mainly non-insulin-dependent diabetes mellitus and retina, kidney, blood vessel, neurological complication; Effect is apparent in view, and product has obtained the approval of national drug authorities, and its trade name is " a YULAN Jiangtang capsule ", and instructions of taking is: oral, every day 2-3 time, each 3.

Embodiments of the invention 1: form by Radix Scutellariae 620 grams, Folium Mori 285 grams, Fructus Arctii 260 grams, Radix Wahlenbergiae Marginatae 180 grams, Herba Scutellariae Barbatae 170 grams, Rhizoma Polygonati Odorati 120 grams, Semen Celosiae 93 grams, more specific method is: get 100 gram powder of Folium Mori and be broken into fine powder, all the other Folium Mori and other medical material water decoct, extracting solution concentrates, add Folium Mori fine powder, drying, pulverizing then, obtain the extract fine powder, in incapsulating.

Embodiments of the invention 2: it is made up of Radix Scutellariae 580 grams, Folium Mori 250 grams, Fructus Arctii 230 grams, Radix Wahlenbergiae Marginatae 150 grams, Herba Scutellariae Barbatae 140 grams, Rhizoma Polygonati Odorati 100, Semen Celosiae 80 grams; Specifically: get 80 gram powder of Folium Mori and be broken into fine powder, all the other Folium Mori and other medical material extract active ingredient with the way that ethanol carries out alcohol extraction, then extracting solution are concentrated, and add Folium Mori fine powder, drying, pulverizing again, obtain medicine, can be made into granule according to prior art.

Embodiments of the invention 3: it is made of Radix Scutellariae 650 grams, Folium Mori 230 grams, Fructus Arctii 300 grams, Radix Wahlenbergiae Marginatae 220 grams, Herba Scutellariae Barbatae 200 grams, Rhizoma Polygonati Odorati 140 grams, Semen Celosiae 110 grams, the active ingredient that can adopt super critical CO 2 technology to extract Chinese herbal medicine, the extraction of substance that obtains are made into the dosage form that needs according to prior art.

Claims

1, a kind of Chinese patent medicine for the treatment of diabetes is characterized in that: according to weight proportion: be made of Radix Scutellariae 580-650, Folium Mori 250-230, Fructus Arctii 230-300, Radix Wahlenbergiae Marginatae 150-220, Herba Scutellariae Barbatae 140-200, Rhizoma Polygonati Odorati 100-140, Semen Celosiae 80-110.

2, according to the Chinese patent medicine of the described this treatment diabetes of claim 1, it is characterized in that: constitute by Radix Scutellariae 620 grams, Folium Mori 285 grams, Fructus Arctii 260 grams, Radix Wahlenbergiae Marginatae 180 grams, Herba Scutellariae Barbatae 170 grams, Rhizoma Polygonati Odorati 120 grams, Semen Celosiae 93 grams.

3, according to the Chinese patent medicine of claim 1,2 described this treatment diabetes, it is characterized in that: get the part powder of Folium Mori and be broken into fine powder, all the other Folium Mori and other medical material water decoct, extracting solution concentrates, add Folium Mori fine powder, drying, pulverizing then, obtain medicine, can be made into the dosage form of needs according to prior art.

4, according to the Chinese patent medicine of claim 1,2 or 3 described this treatment diabetes, it is characterized in that: the extraction of the active ingredient of medical material can be adopted solvent, comprises method and supercritical carbon dioxide extraction that water, alcohol decoct, soak.